Daliom Biopharmaceuticals develops drug delivery systems to help improve the efficacy and safety of existing drugs. This includes developing novel drug delivery technologies that can target specific cells or tissues in the body, as well as developing more effective routes of administration for existing drugs.
Daliom Biopharmaceuticals Ltd. 123 Main Street, Zurich, Switzerland, ZIP Code: 8001. Registration №: CH-123456.7890.12-4.
We refuse unauthorized email collection
We refuse the unauthorized collection of the email addresses on this website using email collection programs or other technical devices. Please note that any violation will be subject to criminal penalties in accordance with the Act on Information and Communications Network.
Posted on March 28, 2023
This site uses cookies.
By continuing to browse the site,
you agree to the use of cookies.
